Moderna's COVID Vaccine Wins FDA Approval for At-Risk Young Children on July 12, 2025 Approved at-risk Child conditions Covid vaccine Moderna Spikevax United States Food and Drug Administration +
Moderna Wins Expanded FDA Approval for RSV Vaccine in At-Risk Younger Adults on June 13, 2025 Adult Approved at-risk chronic health conditions expanded label Moderna mRESVIA RSV vaccine United States Food and Drug Administration +